HOTH Rocket One Inc.

BEARISH Impact: 5/10 8-K
Horizon weeks Filed Jun 3, 2026 Processed 2d 7h ago SEC 0001213900-26-064457
8-K context-dependent: Items 8.01
Latest settled — T+1d ⚠ clustered
HOTH ▼ -7.43% at T+1d
SHORT call ✓ call won +7.43% · α vs SPY +7.83% · entry $2.14 → $1.98
Next anchor: T+5d in 5d
Currently $1.98 · +7.43% from $2.14 entry (call sign-flipped)
Entry anchored
Jun 3, 2026
via day open
T+1d
-7.43%
call +7.43% · α +7.83%
$1.98
settled yesterday
T+5d
call — · α —
in 5d
T+20d
call — · α —
in 27d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Rocket One Inc. increased its at-the-market (ATM) offering capacity by up to $6.829 million in additional common stock, bringing total potential ATM sales to $16.108 million (including $9.279 million already sold). This filing signals ongoing capital needs and potential dilution for existing shareholders.

Actionable Insight

The company is aggressively tapping the ATM facility, having sold $9.3M already and now adding another $6.8M capacity. Monitor for accelerated share sales and potential price pressure. The rapid succession of prospectus supplements (April, May, June) suggests urgent cash needs.

Key Facts

  • Rocket One increased the maximum aggregate offering price under its existing ATM Sales Agreement with H.C. Wainwright by $6,829,000.
  • Approximately $9,279,067 of common stock had already been sold under the agreement prior to this increase.
  • The ATM program was originally established on November 8, 2024, and the company has filed prospectus supplements on April 16, 2026, May 27, 2026, and June 3, 2026.
  • The new shares are offered under an existing S-3 registration statement (No. 333-291566) filed November 17, 2025.

Financial Impact

Up to $6.829 million in additional common stock issuance, on top of $9.279 million already sold.

dilutionshare count

Risk Factors

  • Continued dilution from ATM sales will pressure the stock price.
  • Frequent ATM usage may signal insufficient operating cash flow or difficulty accessing traditional financing.
  • No disclosed use of proceeds — raises uncertainty about capital allocation.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-064457
Document: ea029338301ex5-1.htm0001213900-26-064457
Document: 0001213900-26-064457-index-headers.html0001213900-26-064457
Document: 0001213900-26-064457-index.html0001213900-26-064457
Document: 0001213900-26-064457.txt0001213900-26-064457
10 reports for HOTH
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+1▲ +14.12%May 27, 2026
Filters
Rows
Reports for HOTH — sortable, filterable
Type Now
Jun 3, 2026
2d ago
8-K
NEUTRAL ★ 2/10
$2.14 $1.98▼ −7.43%▼ −7.83%$1.98 (−7.43%)
Jun 3, 2026
2d ago
8-K
BEARISH ★ 5/10
$2.14 $1.98▲ +7.43%▲ +7.83%$1.98 (+7.43%)
Jun 3, 2026
2d ago
424B5
BEARISH ★ 6/10
$2.14 $1.98▲ +7.43%▲ +7.83%$1.98 (+7.43%)
Jun 2, 2026
2d ago
8-K
NEUTRAL ★ 2/10
awaiting T+1
May 28, 2026
8d ago
8-K
MIXED ★ 5/10
$1.70 $1.46▼ −14.12%▼ −14.36%$1.98 (+16.53%)
May 27, 2026
8d ago
424B5
BEARISH ★ 6/10
$1.70 $1.46▲ +14.12%▲ +14.36%$1.98 (−16.53%)
May 27, 2026
9d ago
8-K
NEUTRAL ★ 4/10
$1.36 $1.70▲ +25.00%▲ +24.45%$1.98 (+45.66%)
May 4, 2026
4w ago
8-K
BEARISH ★ 8/10
$0.7100 $0.7400▼ −4.23%▼ −2.84%$1.98 (−179.01%)
Apr 16, 2026
7w ago
8-K
NEUTRAL ★ 4/10
$0.7300 $0.7440▲ +1.92%▲ +2.11%$1.98 (+171.37%)
Apr 16, 2026
7w ago
424B5
BEARISH ★ 5/10
$0.7300 $0.7440▼ −1.92%▼ −2.11%$1.98 (−171.37%)
Showing 10 of 10

US Market Status

Market Open — Closes in 8m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access